Santa Cruz Biotechnology provides a broad selection of CYP4A1 monoclonal antibodies for research focused on understanding CYP4A1 protein function. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP4A1 is a member of the cytochrome P450 superfamily, which plays a crucial role in the metabolism of fatty acids and the synthesis of bioactive lipids. CYP4A1 actively participates in the regulation of blood pressure and inflammation, making it significant in cardiovascular health and disease. Research has shown that CYP4A1 expression levels can vary significantly across different tissues and under various physiological conditions. Understanding CYP4A1 function can provide insights into various pathological conditions, including hypertension and metabolic disorders. Ongoing studies continue to reveal new aspects of CYP4A1's role in cellular processes and disease development. Current research highlights the importance of CYP4A1 in maintaining homeostasis and its potential as a therapeutic target. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of CYP4A1's role in health and disease.